Traxis Partners’s Celgene Corp CELG Stock Holding History

Traxis Partners’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-49,680	Closed	-$2.91M	–	57
2013 Q2	$2.91M	Buy	+49,680	New	+$2.99M	2.25%	13

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Traxis Partners's CELG Position: Q3 2013 in Review

Traxis Partners sold out of Celgene Corp (CELG) in Q3 2013, closing a stake of 49,680 shares — an estimated $2.91M sold.

Traxis Partners first reported a position in CELG in Q2 2013 and held it in 1 quarter. The position peaked at $2.91M in Q2 2013. 909 funds tracked by Wall St. Rank hold CELG as of Q3 2013.

Traxis Partners reported no remaining Celgene Corp position as of Q3 2013 after selling out during the quarter.
Traxis Partners sold 49,680 Celgene Corp shares in Q3 2013, an estimated $2.91M.
Traxis Partners first reported a position in Celgene Corp in Q2 2013 and held it in 1 quarter.
Traxis Partners's Celgene Corp position peaked at $2.91M in Q2 2013.
909 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2013.

Based on Traxis Partners's 13F filing for Q3 2013.